Reading Week 4 Pt. 2🌟
Panic Attack Specifier
Definition: Panic attack is characterized by an abrupt surge of intense fear or discomfort that peaks within minutes and is distinguishable from ongoing anxiety due to its discrete nature and greater severity.
Duration: The intensity of a panic attack typically lasts only a few minutes.
Onset: A panic attack can arise from either calm or anxious states; however, the time to peak intensity must be assessed independently of any preceding anxiety.
The start of a panic attack is identified as the point of abrupt increase in discomfort, not when anxiety first develops.
Return to State: After a panic attack, individuals may return to either an anxious or a calm state, with the possibility of subsequent attacks.
Indicators: Panic attacks are characterized by:
Time to peak intensity occurring within minutes.
Discrete nature of the episodes.
Generally greater severity when compared with ongoing anxiety.
Limited-Symptom Attacks: Attacks that fulfill all criteria but present with fewer than four physical or cognitive symptoms are classified as limited-symptom attacks.
Types of Panic Attacks:
Expected Panic Attacks: Triggered by specific cues or situations previously associated with panic attacks.
Unexpected Panic Attacks: Occur without an obvious trigger; examples include attacks that happen while relaxing or during sleep (nocturnal panic attacks).
Assessment: Clinicians determine whether attacks are expected or unexpected through careful questioning of events leading to the attack and the individual's perception of its onset.
Cultural Considerations: Cultural interpretations can influence the perceived nature of panic attacks and their associated symptoms (e.g., tinnitus, neck soreness). Such culture-specific symptoms do not count toward the four required symptoms for diagnosis but may inform the patient's experience.
Occurrence: Panic attacks can occur in various other mental disorders (e.g., anxiety disorders, psychotic disorders) and medical conditions (e.g., gastrointestinal issues, respiratory diseases), often without meeting the criteria for panic disorder.
Diagnosis of Panic Disorder: Requires recurrent unexpected panic attacks.
Associated Features:
Nocturnal Panic Attacks: Waking from sleep in a panic differs from experiencing panic after fully waking.
Higher rates of suicide attempts and ideation are noted, even considering comorbidities.
Prevalence:
The twelve-month prevalence of panic attacks among U.S. adults is approximately 11.2%.
Prevalence rates are fairly consistent across different racial groups.
European countries show lower prevalence estimates, ranging from 2.7% to 3.3%.
Panic attacks are more common in females than males, especially concerning panic disorder itself.
Rare in preadolescent children; prevalence increases around puberty and declines in older adults.
Development and Course:
Mean age at onset in the U.S. is about 22-23 years. The course often aligns with any co-occurring mental disorders and life stressors.
Rare in children with less disclosure of symptoms, especially among adolescents.
Risk and Prognostic Factors:
Temperamental Factors: High negative affectivity (neuroticism) and anxiety sensitivity are significant risk contributors.
Environmental Factors: Smoking and identifiable stressors before the first attack (e.g., interpersonal issues, health problems).
Cultural and Gender-related Diagnostic Points:
Cultural factors affect the perception of attacks, and the presentation of panic attacks varies across cultures.
Panic attacks are more prevalent in females, though symptom features do not differ by gender.
Diagnostic Markers:
Physiological recordings of panic attacks show sudden increases in arousal (e.g., heart rate) that peak and subside rapidly.
Agoraphobia Diagnostic Criteria 300.22 (F40.00)
Definition: Agoraphobia is marked by intense fear or anxiety about two or more of the following:
Using public transportation (e.g., cars, buses, trains, ships, planes).
Being in open spaces (e.g., marketplaces, parking lots, bridges).
Being in enclosed places (e.g., shops, theaters).
Standing in line or being in crowds.
Being outside of the home alone.
Fear and Avoidance: Individuals may fear or actively avoid these situations for reasons including a belief that escape might be difficult or that help might not be available in case of panic-like symptoms.
Provocation of Fear: Almost always, agoraphobic situations provoke anxiety.
Indicators of Avoidance: Can manifest as:
Actively avoiding situations or needing a companion to endure them with anxiety.
Intense fear or anxiety that is disproportionate to the actual danger posed by these situations.
Persistence: Symptoms must persist for at least 6 months and cause clinically significant distress or impairment.
Contextualizing Symptoms: Fear or avoidance cannot be attributed to another disorder (e.g., social anxiety disorder, specific phobias). Agoraphobia is diagnosed regardless of panic disorder presence.
Diagnostic Features: Endorsement of symptoms across at least two defined situations characterizes agoraphobia and is linked to feelings of dread in such situations.
Associated Features:
Severe forms may lead individuals to become entirely homebound, reliant on others.
Depression and substance abuse can occur as maladaptive self-medication methods.
Prevalence: The annual prevalence among adolescents and adults is about 1.7%, with females being twice as likely as males to experience it. Peaks in late adolescence and early adulthood.
Development and Course: Onset often occurs before age 35, with a chronic trajectory.
Substantial risk factors involve a mix of anxiety and depression coupled with significant life events impacting the course.
Risk and Prognostic Factors:
Behavioral inhibition and anxiety sensitivity are notable temperamental risks.
Early life stressors, negative child-rearing practices, and familial relationships can increase vulnerability.
Genetic Factors: Moderate heritability observed in twin studies; agoraphobia can also manifest in contexts of multiple disorders.
Diagnosis: It is essential to differentiate from disorders with similar traits (e.g., panic disorder, social anxiety disorder), to ensure accurate criteria are met without conflating symptoms.
Generalized Anxiety Disorder Diagnostic Criteria 300.02 (F41.1)
Definition: Characterized by excessive anxiety and worry about a variety of events or activities more days than not, persisting for at least 6 months.
Controlling Worry: Individuals often find it difficult to control their worry.
Symptoms: At least three of the following symptoms should be present (only one symptom required in children):
Restlessness or feeling keyed up.
Being easily fatigued.
Difficulty concentrating or the mind going blank.
Irritability.
Muscle tension.
Sleep disturbance (difficulty falling or staying asleep).
Clinical Impairment: The anxiety and worry must cause clinically significant distress or impairment in social or occupational functioning.
Exclusion Criteria: These symptoms must not result from the physiological effects of a substance or another medical condition.
Distinctiveness Required: The disturbance should not be better accounted for by another mental disorder (e.g., panic disorder, social anxiety disorder).
Diagnostic Features: Anxiety is typically excessive and pervasive, differing from manageable everyday worries which do not significantly hamper functioning.
Associated Features: Individuals experience various somatic symptoms, such as muscle tension, trembling, and autonomic hyperarousal responses.
Prevalence: Lifetime risks for Generalized Anxiety Disorder hover around 9%. Prevalence is higher in females than males; however, factors such as social and cultural contexts may influence reporting.
Course of the Disorder: Symptoms can begin early in life, median onset around 30 years, usually characterized by chronic waxing and waning symptom severity.
Risk Factors: Involves neurotransmitter dysregulation, shared genetic vulnerabilities, and the influence of temperamental and environmental factors.
Comorbidities: High comorbidity across anxiety and mood disorders, with some overlap in symptoms, which necessitates careful assessment for accurate diagnosis.
Substance/Medication-Induced Anxiety Disorder Diagnostic Criteria
Definition: Predominant panic or anxiety symptoms develop during or shortly after substance intoxication, withdrawal, or medication effects.
Evidence Requirement: Diagnosis necessitates both:
Symptoms must stem from the substance's intoxicating effects or withdrawal.
The substance must be capable of producing such symptoms.
Distinctive Symptoms: The anxiety disturbance cannot be better explained by independent anxiety disorder features.
Additional Considerations: Symptoms must cause clinically significant distress or impairment across functional domains (social, occupational, etc.).
Clinical Presentation Identification: Must not occur solely during delirium phases, as these are differentiated based on temporal relationships.
Associated Features: Various substances can elicit anxiety, including stimulants, depressants, and toxic expositional episodes.
Prevalence: Specific prevalence statistics are unclear; more frequent within clinical populations than general populations.
Differential Diagnosis: Essential to assess whether symptoms closely connect to substance exposure, distinguishing them from primary anxiety disorders.
Anxiety Disorder Due to Another Medical Condition Diagnostic Criteria 293.84 (F06.4)
Primary Characteristic: Anxiety symptoms primarily stem from the pathophysiological income of another medical condition.
Evidence from History: Diagnostically require should provide insight into the clarity of temporal relations between anxiety symptoms and the medical condition.
Distinction from Other Disorders: Cannot be better explained by another independent mental disorder.
Duration and Severity: Symptoms must cause notable distress or impairment across everyday life functions.
Clinical Assessment: Comprehensive evaluation is vital to ascertain the relationship of the anxiety symptoms within the context of the medical condition.
Contributory Factors: Examples include endocrine disease, cardiac issues, and neurological disorders that catalyze anxiety responses.